Results 11 to 20 of about 88,263 (338)

Quinones as Neuroprotective Agents [PDF]

open access: goldAntioxidants, 2023
Quinones can in principle be viewed as a double-edged sword in the treatment of neurodegenerative diseases, since they are often cytoprotective but can also be cytotoxic due to covalent and redox modification of biomolecules.
Ángel Cores   +4 more
doaj   +8 more sources

Carbon nanotubes as neuroprotective agents [PDF]

open access: yesExploration of Neuroprotective Therapy
Carbon nanotubes, an emerging class of carbon nanomaterials, possess tremendous potential for application in biotechnology and biomedicine particularly in neurological disorders.
Daisy L. Wilson   +2 more
doaj   +4 more sources

Neuroprotective Agents with Therapeutic Potential for COVID-19 [PDF]

open access: goldBiomolecules, 2023
COVID-19 patients can exhibit a wide range of clinical manifestations affecting various organs and systems. Neurological symptoms have been reported in COVID-19 patients, both during the acute phase of the illness and in cases of long-term COVID ...
César A. Zaa   +4 more
doaj   +4 more sources

Neuroprotective Properties of Chitosan and Its Derivatives

open access: yesMarine Drugs, 2010
Neuronal cells are extremely vulnerable and have a limited capacity for self-repair in response to injury. For those reasons, there is obvious interest in limiting neuronal damage.
Se-Kwon Kim, Ratih Pangestuti
doaj   +5 more sources

The Promise of Neuroprotective Agents in Parkinson’s Disease [PDF]

open access: yesFrontiers in Neurology, 2011
Parkinson’s Disease is characterized by loss of dopamine neurons in the substantia nigra of the brain. Since there are limited treatment options for PD, neuroprotective agents are currently being tested as a means to slow disease progression.
Judith ePotashkin, Stacey E Seidl
doaj   +4 more sources

Neuroprotective Agents in the Intensive Care Unit - Neuroprotective Agents in ICU -

open access: yesJournal of Pharmacopuncture, 2018
Neuroprotection or prevention of neuronal loss is a complicated molecular process that is mediated by various cellular pathways. Use of different pharmacological agents as neuroprotectants has been reported especially in the last decades.
Yunes Panahi   +5 more
doaj   +3 more sources

Fiscalin Derivatives as Potential Neuroprotective Agents [PDF]

open access: yesPharmaceutics, 2022
Neurodegenerative diseases (ND) share common molecular/cellular mechanisms that contribute to their progression and pathogenesis. In this sense, we are here proposing new neuroprotection strategies by using marine-derived compounds as fiscalins.
Sandra Barreiro   +6 more
doaj   +2 more sources

Thiourea-Based H2S-Releasing Pramipexole Hybrids as Neuroprotective Agents [PDF]

open access: yesAntioxidants
Multitarget hybrid molecules are a promising strategy for treating complex neurodegenerative disorders such as Parkinson’s disease (PD), where dopaminergic dysfunction, oxidative stress, neuroinflammation, and cellular senescence coexist and drive ...
Angela Corvino   +12 more
doaj   +2 more sources

A Review of Neuroprotective Agents [PDF]

open access: yesCurrent Medicinal Chemistry, 2004
The brain remains an area where little corrective surgery can be performed and the reversal of damage is almost impossible. Recently, reports of agents offering neuroprotection have begun to appear in the literature. The concept of neuroprotection is the
Levi, MS, Brimble, MA
core   +3 more sources

Mechanisms and Potential Benefits of Neuroprotective Agents in Neurological Health. [PDF]

open access: yesNutrients
The brain contains many interconnected and complex cellular and molecular mechanisms. Injury to the brain causes permanent dysfunctions in these mechanisms.
Pekdemir B   +6 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy